Literature DB >> 31514523

Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography.

Kasper Korsholm1, Jesper Møller Jensen1, Bjarne Linde Nørgaard1, Jens Erik Nielsen-Kudsk1.   

Abstract

BACKGROUND: Device-related thrombosis (DRT) following left atrial appendage occlusion is a rare but feared complication. The diagnostic value of cardiac compute tomography (CT) for detection of DRT is unknown. This study sought to evaluate the clinical value of cardiac CT for detection of DRT using transesophageal echocardiography (TEE) as the reference standard and to provide insights into the causes, natural history, and risk of DRT.
METHODS: We reviewed 301 consecutive patients undergoing left atrial appendage occlusion at Aarhus University Hospital, Denmark, between 2010 and 2017. Of these, 248 patients had cardiac CT and TEE imaging available at 8-week follow-up; 139 had complete 12-month imaging. A blinded investigator analyzed all images. On TEE, an echo-dense mass attached to the device was defined as DRT. Cardiac CT was analyzed for presence of hypoattenuated thickening (HAT) on the device, which was subclassified as low grade or high grade. High-grade HAT was considered as definite DRT.
RESULTS: At 8 weeks, TEE detected 5 (2%) cases with DRT; and cardiac CT 6 (2.4%) cases with high-grade HAT. At 12 months, both TEE and cardiac CT detected 2 (1.4%) cases with DRT or high-grade HAT, respectively. Cardiac CT demonstrated low-grade HAT in 9 (3.6%) cases at 8 weeks; and 13 cases (9.4%) at 12-months. High-grade HAT/DRT was associated with thromboembolism in 2 cases, whereas low-grade HAT was not related to embolic events. Low-grade HAT resolved spontaneously over time.
CONCLUSIONS: Cardiac CT seems equally good as TEE for detection of DRT. In addition, cardiac CT demonstrates cases with low-grade HAT, not visualized by TEE. The clinical significance hereof requires further investigation.

Entities:  

Keywords:  atrial appendage; echocardiography, transesophageal; registries; risk; thrombosis

Mesh:

Year:  2019        PMID: 31514523     DOI: 10.1161/CIRCINTERVENTIONS.119.008112

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  3 in total

Review 1.  Left atrial appendage exclusion in atrial fibrillation.

Authors:  Guy Rozen; Gilad Margolis; Ibrahim Marai; Ariel Roguin; Eldad Rahamim; David Planer; Edwin Kevin Heist; Offer Amir; Ilgar Tahiroglu; Jeremy Ruskin; Moussa Mansour; Gabby Elbaz-Greener
Journal:  Front Cardiovasc Med       Date:  2022-09-13

2.  Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices.

Authors:  Kasper Korsholm; Jesper M Jensen; Bjarne L Nørgaard; Jens E Nielsen-Kudsk
Journal:  Catheter Cardiovasc Interv       Date:  2022-05-18       Impact factor: 2.585

3.  Value of FEops HEARTguide patient-specific computational simulations in the planning of left atrial appendage closure with the Amplatzer Amulet closure device: rationale and design of the PREDICT-LAA study.

Authors:  Philippe Garot; Xavier Iriart; Adel Aminian; Joelle Kefer; Xavier Freixa; Ignacio Cruz-Gonzalez; Sergio Berti; Liesbeth Rosseel; Reda Ibrahim; Kasper Korsholm; Jacob Odenstedt; Jens-Erik Nielsen-Kudsk; Jaqueline Saw; Lars Sondergaard; Ole De Backer
Journal:  Open Heart       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.